Imperative Care news
Imperative Care, Inc. announced today that the first patient has been enrolled in the Imperative Trial. This prospective, multi-center clinical trial is the first study designed to evaluate the clinical benefits of direct aspiration for the treatment of ischemic stroke with the Zoom 88 Large Distal Platform, which is currently FDA cleared for neurovascular access. Additionally, the trial will gather data on the clinical benefits of the full Zoom Stroke Solution™, the company&rsquo
- Holly Sheffield, Medical Technology Executive and Investment Banker
- Hank Plain, Serial Entrepreneur, Executive and Venture Capital Leader
- James Rogers, Public and Private Medical Technology Investor
Imperative Care, Inc. today announced three appointments to the company’s Board of Directors with the addition of Holly Sheffield, Hank Plain, and James Rogers.
“We are gr
Imperative Care, Inc. today announced that it has closed a $260 million Series D financing led by D1 Capital Partners L.P. New investors HealthCor Investments LLC and Innovatus Capital Partners, LLC also joined the
Imperative Care, Inc., a company singularly dedicated to answering unsolved problems in stroke, today announced that Matthew Garrett has been appointed as the company’s Chief Financial Officer. Mr. Garrett is a seasoned fina
Imperative Care, Inc., a company singularly dedicated to addressing unsolved problems in stroke, today announced that its Chief Operating Officer, Daniel Davis, has been appointed as the company’s President. Mr. Davis will o